Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 4:68:e230505.
doi: 10.20945/2359-4292-2023-0505. eCollection 2024.

Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates

Marise Codeco de Andrade Barreto  1   2 , Natalia Treistman  2 , Lara Bessa Campelo Pinheiro Cavalcante  2 , Daniel Bulzico  1 , Fernanda A de Andrade  1 , Rossana Corbo  1 , Paulo Alonso Garcia Alves Jr  1   2 , Fernanda Vaisman  1   2
Affiliations

Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates

Marise Codeco de Andrade Barreto et al. Arch Endocrinol Metab. .

Abstract

Objective: Patients with pediatric differentiated thyroid carcinoma (DTC) treated with radioiodine (RAI) therapy may experience long-term side effects, such as gonadal dysfunction. Therefore, it is crucial to understand the impact of this therapy on ovarian reserve and future pregnancy rates.

Subjects and methods: Retrospective analysis of 64 female DTC survivors of childbearing age to assess the risk of infertility due to RAI performed before the age of 19 years.

Results: Thirty-two out of the 64 DTC survivors had a history of at least one pregnancy during follow-up. No significant differences were observed between the cumulative RAI activity, treatment regimens (multiple versus single RAI treatment), age at first treatment, or presence of lymph node or distant metastases. Notably, the group without a history of pregnancy had a younger age at the time of diagnosis and larger tumors. Age at first pregnancy was slightly higher than that in the general population, but no increase in negative maternal or fetal outcomes was observed.

Conclusions: The results of this study show little observational evidence suggesting important adverse effects of RAI on fertility or pregnancy outcomes among female survivors of childhood DTC. Still, studies including larger populations are warranted.

Keywords: Pregnancy; pediatric thyroid cancer; radioiodine.

PubMed Disclaimer

Conflict of interest statement

Disclosure: no potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1. Flowchart of the study cohort for analysis of female fertility.
See this image and copyright information in PMC

References

    1. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006 Oct 12;355(15):1572–1582. doi: 10.1056/NEJMsa060185. - DOI - PubMed
    1. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, et al. Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings. J Clin Oncol. 2009 May 10;27(14):2339–2355. doi: 10.1200/JCO.2008.21.1953. - DOI - PMC - PubMed
    1. Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013 Aug;14(9):873–881. doi: 10.1016/S1470-2045(13)70251-1. - DOI - PMC - PubMed
    1. Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of Female Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2009 Jun 1;27(16):2677–2685. doi: 10.1200/JCO.2008.20.1541. - DOI - PMC - PubMed
    1. Navarro P, Rocher S, Miró-Martínez P, Oltra-Crespo S. Radioactive iodine and female fertility. Sci Rep. 2022 Mar;8(12):3704–3704. doi: 10.1038/s41598-022-07592-8. - DOI - PMC - PubMed

Substances

LinkOut - more resources